ARTICLE

Evidence of Oxidative Stress in Human Corneal Diseases

Correspondence to: Donald J. Brown, Ophthalmology Research, Cedars–Sinai Medical Center, D-5069, 8700 Beverly Blvd., Los Angeles, CA 90048. E-mail: brown2@cshs.org

	Summary

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

This study localized malondialdehyde (MDA, a toxic byproduct of lipid peroxidation), nitrotyrosine [NT, a cytotoxic byproduct of nitric oxide (NO)], and nitric oxide synthase isomers (NOS) in normal and diseased human corneas. Normal corneas (n=11) and those with clinical and histopathological diagnoses of keratoconus (n=26), bullous keratopathy (n=17), and Fuchs' endothelial dystrophy (n=12) were examined with antibodies specific for MDA, NT, eNOS (constitutive NOS), and iNOS (inducible NOS). Normal corneas showed little or no staining for MDA, NT, or iNOS, whereas eNOS was detected in the epithelium and endothelium. MDA was present in all disease groups, with each group displaying a distinct pattern of staining. NT was detected in all keratoconus and approximately one half of Fuchs' dystrophy corneas. iNOS and eNOS were evident in all the diseased corneas. Keratoconus corneas showed evidence of oxidative damage from cytotoxic byproducts generated by lipid peroxidation and the NO pathway. Bullous keratopathy corneas displayed byproducts of lipid peroxidation but not peroxynitrite (MDA but not NT). Conversely, Fuchs' dystrophy corneas displayed byproducts of peroxynitrite with little lipid peroxidation (NT >> MDA). These data suggest that oxidative damage occurs within each group of diseased corneas. However, each disease exhibits a distinctive profile, with only keratoconus showing prominent staining for both nitrotyrosine and MDA. These results suggest that keratoconus corneas do not process reactive oxygen species in a normal manner, which may play a major role in the pathogenesis of this disease.

(J Histochem Cytochem 50:341–351, 2002)

Key Words: peroxynitrite, nitric oxide, nitrotyrosine, keratoconus, bullous keratopathy, Fuchs' endothelial dystrophy, malondialdehyde, lipid peroxidation

	Introduction

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

THE CORNEA is a transparent avascular tissue that allows transit of incident light to the more posterior ocular structures. Therefore, this tissue is constantly exposed to a wide spectrum of light, including the ultraviolet (UV) range. UV exposure is a well-documented environmental stress factor that generates free radicals and reactive oxygen species detrimental to most cells and tissues (Wenk et al. 2001 ). The cornea absorbs most of the UV entering the eye, suggesting that the cornea would be especially susceptible to damage from reactive oxygen species (ROS). In the healthy cornea, a number of defensive mechanisms are present to minimize and reduce this risk. Indeed, 20–40% of the soluble protein content of the cornea is an isoenzyme of aldehyde dehydrogenase (ALDH3), which directly absorbs UV and removes cytotoxic aldehydes produced by UV-induced lipid peroxidation (Abedinia et al. 1990 ; Gondhowiardjo et al. 1991 ). Animal studies have shown that this enzyme plays an important protective role in preventing UV damage and that mouse strains expressing enzymatically defective ALDH3 are especially susceptible to UV-induced pathology (Downes et al. 1993 , Downes et al. 1997 ; Shiao et al. 1999 ; Pappa et al. 2001 ). Furthermore, the cornea is rich in antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase, and glutathione reductase, all of which help in the removal of free radicals and ROS generated by constant absorption of UV light (Rao et al. 1987 ). Surprisingly, the potential role of oxidative damage in common human corneal diseases has not been thoroughly investigated.

The most common indications for corneal transplantation are keratoconus and bullous keratopathy (Liu and Slomovic 1997 ; Lois et al. 1997 ; Cursiefen et al. 1998 ). Keratoconus is a non-inflammatory disorder that occurs in young adults (second to fourth decade) and its hallmarks are focal scarring, breaks in Bowman's layer, and thinning of the corneal stroma (Kenney et al. 2000 ; Zhou et al. 1996 ). As the cornea thins, patients have irregular corneal astigmatism that can lead to severe visual distortion (Krachmer et al. 1984 ; Rabinowitz 1998 ). In contrast, bullous keratopathy patients are typically older (past the fifth decade) with corneas that are edematous, fibrotic, and occasionally vascularized. Bullous keratopathy typically occurs after surgical intervention for cataract removal with (pseudophakic) or without (aphakic) placement of an intraocular lens. Fuchs' endothelial dystrophy is another corneal disorder in which altered fluid balance leads to excessive swelling of the stroma, loss of transparency, and decreased visual acuity. It has a hereditary component, occurring as early as the fourth decade of life, and patients may require a corneal transplant well before the formation of any cataract.

Recently, several lines of evidence have emerged suggesting that corneal components involved in protection against oxidative damage are altered in these disorders. ALDH3 is reportedly abnormal in keratoconus corneas (Gondhowiardjo and van Haeringen 1993 ; Gondhowiardjo et al. 1993 ). Extracellular forms of SOD have been reported to be depressed in both keratoconus and bullous keratopathy (Behndig et al. 1998 , Behndig et al. 2001 ). Although these changes suggest that the corneas are more susceptible to UV-induced damage, no direct evidence of this type of damage is present. It is not clear whether diseased corneas, specifically keratoconus and bullous keratopathy corneas, accumulate byproducts of oxidative damage.

Lipid peroxidation occurs in response to elevated levels of ROS with the liberation of reactive aldehydes, such as malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE) (Gutteridge and Halliwell 1990 ; Esterbauer et al. 1991 ). In vitro studies show that MDA crosslinks via Schiff-base conjugation with primary amino groups of phospholipids (Bhuyan et al. 1996 ) and proteins (Ganea and Harding 2000 ). Therefore, demonstration of the MDA hapten in tissues is considered evidence of lipid peroxidation. Similarly, nitric oxide (NO), which serves as a mediator in diverse processes throughout the eye (Becquet et al. 1997 ), can have cytotoxic effects. The cytotoxic effects of NO are mediated by peroxynitrite, a potent oxidant produced by the rapid reaction of NO and superoxides (see Fig 1) (Beckman and Koppenol 1996 ). Peroxynitrite reacts with proteins, non-protein sulfhydryls, methionine, DNA, and phospholipids (Beckman 1996 ; Kooy et al. 1997 ; Murphy et al. 1998 ). Peroxynitrite reacts with the phenolic ring of tyrosine to form a stable product, nitrotyrosine (NT) (Kooy et al. 1995 ; Beckman and Koppenol 1996 ). Demonstration of NT residues is therefore considered a specific marker for peroxynitrite and nitrogen-related oxidants (Kooy et al. 1995 , Kooy et al. 1997 ; Cross et al. 1997 ; Saleh et al. 1997 ).

View larger version (22K): [in this window] [in a new window]   Figure 1. Schematic of oxidative pathways.

In this study we examined over 90 corneas for evidence of oxidative damage. Using antibodies to detect MDA (lipid peroxidation), NOS isoenzymes (nitric oxide production), and NT (peroxynitrite), we demonstrated that (a) NT appeared differentially in diseased corneas (keratoconus > Fuchs' dystrophy > bullous keratopathy > normal), (b) eNOS could be found in both normal and diseased corneas, but iNOS was found only in the diseased corneas, (c) in keratoconus corneas at the site of Bowman's layer breaks, positive staining for NT correlated with the appearance of iNOS, and (d) MDA was also differentially associated with diseased corneas: keratoconus > bullous keratopathy > Fuchs' dystrophy > normal. These observations provide direct evidence that oxidative damage occurs in common human corneal disorders. Importantly, the distinct MDA and NT staining patterns for each disorder may give valuable clues to the underlying mechanisms involved in their pathogenesis.

	Materials and Methods

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

Archived formalin-fixed, paraffin-embedded corneas with confirmed clinical and histological diagnoses of keratoconus (n=26), bullous keratopathy (n=17), and Fuchs' endothelial dystrophy (n=12) were obtained for this retrospective analysis. Eleven normal corneas with no histopathological changes were also included in this study. Five-micrometer sections were mounted on poly-L-lysine coated slides. After deparaffinization and hydration, sections were incubated and permeabilized in 0.1% aqueous saponin at room temperature (RT) for 60 min and then rinsed three times in PBS. Endogenous peroxidase activity was blocked in all tissues by a 5-min incubation in 3% hydrogen peroxide (Sigma Chemical; St Louis, MO). The sections were incubated overnight at 4C with the following antibodies: (a) rabbit polyclonal anti-iNOS (the inducible isoform of NOS), raised to a 21-kD protein fragment corresponding to amino acids 961–1144 of mouse macrophage iNOS (#N32030; Transduction Laboratories, San Diego, CA); (b) mouse monoclonal anti-eNOS (endothelial NOS), raised to a 20-kD protein fragment corresponding to amino acids 1030–1209 of human eNOS (#N30020, Transduction Laboratories); (c) mouse monoclonal antibody to nitrotyrosine (clone 1A6; Upstate Biotechnology, Lake Placid, NY) or rabbit polyclonal antibody to nitrotyrosine (raised against nitrated keyhole limpet hemocyanin; Upstate Biotechnology), and (d) rabbit anti-MDA antiserum (#MDA 11-C; Alpha Diagnostics, San Antonio, TX). This was followed by incubation (60 min, RT) in biotinylated anti-mouse or anti-rabbit secondary antibodies (Vector Laboratories; Burlingame, CA). The immunolabeled sites were visualized using an avidin–biotin–peroxidase kit (Vector) with diaminobenzidine tablets (Sigma) used at the development stage. All sections were allowed to develop for 15 min, then immediately washed and counterstained with Mayer's hematoxylin (Sigma).

Corneas with fungal keratitis were used as a positive control for NT, iNOS, and eNOS. Negative controls included omission of the primary antibody and equimolar concentrations of purified IgG from normal rabbit serum (for the polyclonal primary antibodies). These samples were routinely negative. To confirm the specificity of the staining for nitrotyrosine the antibody was incubated with 10 mM nitrotyrosine as previously described (Beckman 1996 ; Kooy et al. 1997 ; Murphy et al. 1998 ). In addition, some tissue sections were treated with fresh 1 M sodium hydrosulfite (pH 9) for 3 min to reduce any tissue nitrotyrosine to aminotyrosine. Sodium hydrosulfite was prepared immediately before use in 0.05 M Tris-Hcl/0.15 M NaCl buffer and the pH was subsequently adjusted to 9 with sodium hydroxide. In some experiments, the activities of polyclonal antibodies to iNOS and eNOS were neutralized by pre-incubation with an excess of the respective specific blocking peptides against which the antibodies were raised. In both cases, this procedure completely abolished the staining, confirming the specificity of the antibodies.

The sections were examined and photographed with Kodak Ektachrome film using an Olympus BH-2 microscope. The developed prints were digitized using a MicroTek scanner and printed with an Epson Photo printer. Statistical analysis was performed using Fisher's exact test. p<0.05 was considered significant.

	Results

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

Lipid peroxidation occurs in response to elevated levels of ROS. This can lead to cell membrane destruction with the liberation of reactive aldehydes, such as malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE) (Gutteridge and Halliwell 1990 ; Esterbauer et al. 1991 ). Lipid peroxidation and reactive aldehydes are associated with chronic liver diseases, aging, amyotrophic lateral sclerosis, ischemia, and diabetes mellitus (Paradis et al. 1997 ; Yoshino et al. 1997 ; Ohhira et al. 1998 ; Pedersen et al. 1998 ). We examined archived human tissue by immunohistochemistry for the presence of MDA and, by extension, lipid peroxidation in diseased corneas.

Normal human corneas generally lacked MDA staining in any of the tissue layers (Fig 2A and Fig 2B; Table 1). The single case showing trace staining with this antibody is shown in Fig 2A. Bullous keratopathy corneas consistently had a positively stained epithelium, with strong diffuse staining in areas of subepithelial fibrosis (SEF: Fig 2C). The posterior collagenous layer (also referred to as the retrocorneal fibrous membrane) was also strongly positive for MDA in these corneas (Fig 2D). About two thirds of Fuchs' dystrophy corneas stained with MDA in the epithelium (Fig 2E) but were consistently negative in the posterior cornea, including the abnormal guttae associated with Descemet's membrane (Fig 2F). Keratoconus corneas were strongly stained for MDA in the epithelium and in areas of stroma adjacent to breaks in Bowman's layer (Fig 2G and Fig 2H). These observations indicate that, in these disease states, the cornea accumulates byproducts of lipid peroxidation.

View larger version (79K): [in this window] [in a new window]   Figure 2. MDA immunoreactivity in the various disease groups. Normal (A,B), bullous keratopathy (C,D), Fuchs' dystrophy (E,F), and keratoconus corneas (G,H) were stained for MDA. Note that Bowman's layer (bl) is disrupted in keratoconus. e, epithelium; s, stroma; sef, subepithelial fibrosis; pcl, posterior collagenous layer; dm, Descemet's membrane; g, guttae. Bars = 60 µm.

Nitric oxide, produced by oxidative deamination of L-arginine by NOS, serves as a mediator in diverse and complex cellular processes throughout the eye (Becquet et al. 1997 ). Increased production of NO, however, can have cytotoxic effects mediated by peroxynitrite, a potent oxidant produced by the rapid reaction of NO and superoxides (see Fig 1) (Beckman and Koppenol 1996 ). Demonstration of NT residues is considered a specific marker for peroxynitrite and nitrogen-related oxidants (Cross et al. 1997 ; Kooy et al. 1995 , Kooy et al. 1997 ; Saleh et al. 1997 ). We therefore examined these corneas for immunoreactivity using both monoclonal and polyclonal antibodies to NT.

Specific patterns staining for NT were evident in the keratoconus (Fig 3G and Fig 3H) and Fuchs' endothelial dystrophy (Fig 3E) corneas, whereas minimal or no staining was seen in the normal (Fig 3A and Fig 3B) or bullous keratopathy corneas (Fig 3C and Fig 3D). It was interesting that bullous keratopathy corneas, which stained well for MDA in areas of subepithelial fibrosis and the posterior collagenous layer, lacked any detectable staining for NT. In keratoconus corneas, NT staining was extensive throughout the epithelial layer and extended into the stroma adjacent to disruptions in Bowman's layer (Fig 3G and Fig 3H). NT staining was completely blocked by pre-incubation of the antibody with 10 mM nitrotyrosine, thus confirming the specificity of the positive staining (Fig 4B). In addition, pretreatment of tissue sections with sodium hydrosulfite (to reduce nitrotyrosine to aminotyrosine) led to either markedly reduced staining or no staining at all (Fig 4C).

View larger version (69K): [in this window] [in a new window]   Figure 3. Nitrotyrosine (NT) immunoreactivity in the various disease groups. Normal (A,B), bullous keratopathy (C,D), Fuchs' dystrophy (E,F), and keratoconus corneas (G,H) were stained for nitrotyrosine. e, epithelium; s, stroma; sef, subepithelial fibrosis; pcl, posterior collagenous layer; dm, Descemet's membrane; g, gutta. Bars = 60 µm.

View larger version (68K): [in this window] [in a new window]   Figure 4. Specificity of nitrotyrosine staining. (A) A keratoconus section stained with anti-NT. (B) Reduced staining when the primary antibody was incubated with excess nitrotyrosine. (C) When the sections were incubated with fresh sodium hydrosulfite before incubation with primary antibody, staining was also markedly reduced. Bars = 60 µm.

Because NT staining suggested that the diseased corneas produced peroxynitrite, it was of interest to determine whether these corneas also produced NO locally. Therefore, each cornea was stained for the presence of both eNOS and iNOS. Immunoreactivity for eNOS was noted in normal corneas in the epithelium and endothelium but was not apparent in stromal cells (Fig 5A and Fig 5B). All other corneas stained clearly with this antibody in both the epithelial and endothelial layers of the tissue (Fig 5C–5H). It was notable that keratoconus corneas displayed eNOS staining in stromal cells in areas adjacent to breaks in Bowman's layer (Fig 5G) and bullous keratopathy in posterior stromal cells (Fig 5D). In contrast to eNOS, iNOS antibody staining was absent or minimal in the normal corneas (Fig 6A). All the diseased corneas had increased iNOS staining in the epithelium compared to normal corneas (Fig 6A–6C and Fig 6E). In bullous keratopathy, cells throughout the cornea showed weak but detectable staining (Fig 6C and Fig 6D), which was similar to the eNOS pattern. Fuchs' dystrophy was notable in that the cells near guttae (Fig 6F) were stained for iNOS. Again, keratoconus corneas displayed the most intense staining of all the corneas (Fig 6B) with all cell layers showing staining.

View larger version (119K): [in this window] [in a new window]   Figure 5. eNOS immunoreactivity in the various disease groups. Normal (A,B), bullous keratopathy (C,D), Fuchs' dystrophy (E,F), and keratoconus corneas (G,H) were stained for eNOS. e, epithelium; s, stroma; sef, subepithelial fibrosis; pcl, posterior collagenous layer; dm, Descemet's membrane; g, guttae. Bars = 60 µm.

View larger version (109K): [in this window] [in a new window]   Figure 6. iNOS immunoreactivity in the various disease groups. Normal (A), bullous keratopathy (C,D), Fuchs' dystrophy (E,F), and keratoconus corneas (B) were stained for iNOS. e, epithelium; s, stroma; sef, subepithelial fibrosis; pcl, posterior collagenous layer; dm, Descemet's membrane; g, guttae. Bars = 60 µm. Figure 7. Distribution of NT and iNOS in serial sections. (A) A keratoconus cornea showing typical distribution of NT staining in epithelial layers as well as focal staining in superficial stroma adjacent to Bowman's layer breaks (bl, arrows) and (B) iNOS staining showing a distribution pattern similar to that seen with NT. Bars = 60 µm.

The staining patterns for iNOS and NT appeared to correlate with each other. To more carefully assess this relationship, serial sections of keratoconus cases were stained for these antigens and examined. As shown in Fig 7, areas staining well with NT (Fig 7A) corresponded to areas enriched for iNOS staining (Fig 7B).

	Discussion

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

Because the cornea absorbs approximately 80% of the incident ultraviolet B (UVB) light, there is a potential for generating significant amounts of free radicals and ROS. We undertook this study to look for evidence of oxidative damage in common human corneal disorders. Because there are multiple pathways of ROS/free radical cytotoxicity, we probed for the byproducts of two prominent pathways, MDA (lipid peroxidation) and NT (peroxynitrite formation).

Malondialdehyde (MDA)
Lipid peroxidation results from UV-induced oxidative destruction of cell membranes and the formation of cytotoxic aldehydes. These aldehydes can result in altered enzyme activities, inhibition of DNA/RNA/protein synthesis, and other damaging events (Esterbauer et al. 1991 ). This is the first study to document the presence of the toxic aldehyde byproduct MDA in human diseased corneas. In normal corneas, high levels of ALDH3 and SOD are present (Gondhowiardjo and van Haeringen 1993 ; Behndig et al. 1998 ; Pappa et al. 2001 ) and presumably function to absorb UV and scavenge both free oxygen radicals (SOD) and the generated aldehydes (ALDH3). Little evidence of MDA staining in normal corneas was obtained in this study. In contrast, all of the disease groups examined here showed significant and distinct patterns of MDA staining (Fig 2). In Fuchs' endothelial dystrophy, only the epithelial layer showed staining, whereas in keratoconus or bullous keratopathy corneas additional staining was observed. In bullous keratopathy, this staining appeared to be associated with areas of subepithelial fibrosis and, in another area of fibrotic change, the posterior collagenous layer. In keratoconus, stromal areas adjacent to regions where Bowman's layer was disrupted also stained for MDA. Because these regions are also associated with fibrosis (Kenney et al. 1998 , Kenney et al. 2000 , Kenney et al. 2001 ), MDA staining may represent an association with fibrosis in the cornea.

Nitrotyrosine
Several biochemical processes have been implicated in the pathogenesis of keratoconus (Kenney et al. 2000 ). In this study, keratoconus corneas consistently showed significant NT staining compared to normal corneas, which were routinely negative (Fig 3). The only other disease group that had NT staining was the Fuchs' dystrophy corneas. Bullous keratopathy corneas lacked NT staining, even if there was a significant amount of subepithelial fibrosis or a thick posterior collagenous layer (Fig 3C and Fig 3D), indicating that fibrosis per se does not involve the accumulation of peroxynitrite byproducts. In contrast, Fuchs' endothelial dystrophy, which clinically has similar signs and symptoms as bullous keratopathy, does accumulate NT in the epithelium.

Nitric Oxide Synthase
The cornea contains all the biochemical pathways necessary for free radical generation as well as free radical quenching. Corneal cells are capable of expressing isoforms of the NOS, suggesting that significant quantities of NO are produced physiologically in the cornea (Dighiero et al. 1997 ; McMenamin and Crewe 1997 ). In the cornea, eNOS activity has been demonstrated in the epithelium and endothelium (Yanagiya et al. 1997 ). The NO/cGMP pathway may be important in preventing corneal edema and maintaining normal corneal thickness (Yanagiya et al. 1997 ). iNOS can be found in corneal endothelial cells after induction by lipopolysaccharide (LPS) and cytokines (Dighiero et al. 1997 ).

This study provides information about the distribution of eNOS in normal and diseased corneas. In agreement with others (Yanagiya et al. 1997 ), we found that, in normal corneas, eNOS was expressed only in the epithelium and endothelium (Fig 5A and Fig 5B). Consistent with this, all three diseases showed continued eNOS expression in the epithelium and endothelium. iNOS staining was essentially absent in normal corneas (Fig 6A) but was localized to the epithelial, stromal, and endothelial cells in all three disease groups.

Finding both eNOS and iNOS in the diseased corneas certainly suggests that higher amounts of NO are present within the tissue, but this may not translate into increased NT or oxidative stress byproducts. As mentioned previously, the majority of bullous keratopathy corneas had both eNOS and iNOS but lacked NT/peroxynitrite staining. Even Fuchs' dystrophy corneas consistently displayed these NOS isoenzymes, but only a few corneas showed NT staining. This suggests that, even with ongoing disease, human corneas can adequately process the free radicals/ROS so that the cytotoxic peroxynitrite byproduct was not formed. Keratoconus appeared to lack this capacity because all these corneas showed consistent NT staining that correlated with iNOS distribution (Fig 7).

The increased formation of nitrotyrosine (peroxynitrite) and MDA in keratoconus corneas (and, to a lesser extent, in Fuchs' dystrophy and bullous keratopathy corneas) suggests an important role of free radicals in their pathogenesis. Peroxynitrite-mediated tyrosine nitration as well as peroxynitrite itself can lead to altered biological functions (Estrada et al. 1997 ; Go et al. 1999 ; Jope et al. 2000 ; Kiroycheva et al. 2000 ). Structural proteins appear to be major targets for nitration by peroxynitrite with resultant disruption of their polymeric structure (Beckman 1996 ; Beckman and Koppenol 1996 ). In keratoconus, such a mechanism could, over a period of time, cause alterations of the stromal collagen molecules, perhaps making them more susceptible to digestion by activated enzymes and leading to stromal thinning. In addition to the effect on proteins, both NO and peroxynitrite are involved in multiple cytotoxic pathways. Both NO and peroxynitrite are toxic to DNA, leading to mutations and strand breaks (Szabo and Ohshima 1997 ). In this context, it is important to note that sustained exposure to low levels of NO or peroxynitrite can trigger apoptosis (Szabo and Ohshima 1997 ), and increased apoptotic activity has been reported in keratoconus corneas (Kim et al. 1999 ), possibly playing a role in its pathogenesis.

The relationship between MDA, NT, and NOS isoenzymes has been examined in a rat iron-overload renal system (Zhou et al. 2000 ). Upregulation of eNOS, iNOS, NT, and MDA was found in these animals. This is interesting because keratoconus corneas, which had increases of both MDA and NT, classically have distinct iron rings (Fleischer's ring) at the base of the cone. Iron accelerates lipid peroxidation of cell membranes (Zhou et al. 2000 ) and its presence may lead to oxidative damage. It should also be noted that the increased oxidative damage found in keratoconus corneas is probably not related to duration of exposure to UV light (age-related). In general, keratoconus is first diagnosed in mid-teen to early 20-year-old patients, while the bullous keratopathy patients are well into the fifth to sixth decades of life and have undergone cataract surgery before they have corneal problems.

More recently, alterations in the corneal enzymes ALDH3 and extracellular SOD, required to process and scavenge free radicals, have been reported in association with human corneal disease (Gondhowiardjo and van Haeringen 1993 ; Gondhowiardjo et al. 1993 ; Behndig et al. 2001 ). ALDH3 is known to participate in protecting the cornea against UV damage and aldehyde formation. If ALDH3, reported to be altered in keratoconus, were functionally impaired, one would expect increases in aldehyde damage and the accumulation of byproducts such as MDA. Although no changes in ALDH3 have been reported associated with bullous keratopathy and Fuchs' dystrophy, we predict that this may be the case because MDA is present in these diseases. In addition, both keratoconus and bullous keratopathy have reduced levels of SOD (Behndig et al. 2001 ), an oxygen radical scavenger. This could account for the accumulation of MDA in these tissues. Decreased SOD activity, coupled with increased NO production, could also account for the nitrotyrosine accumulation.

To conclude, we demonstrated unique patterns of NT/peroxynitrite and/or MDA distribution in keratoconus, bullous keratopathy, and Fuchs' endothelial dystrophy corneas. The excessive amounts of both NT and MDA in the keratoconus corneas support the hypothesis that oxidative damage plays an important role in this corneal disease. In addition, although bullous keratopathy patients and Fuchs' dystrophy patients often have similar clinical symptoms, their NT and MDA staining patterns are different from each other, with MDA correlating with fibrotic changes and NT correlating with iNOS distribution, suggesting that the pathophysiological pathways may not be identical.

	Acknowledgments

Supported by NIH EY06807 and EY10836, the Schoellerman Charitable Foundation, the Discovery Fund for Eye Research, the Skirball Molecular Ophthalmology Program, and the National Keratoconus Foundation.

The authors wish to thank Dr. Narsing Rao (Doheny Eye Institue, Los Angeles) for his helpful comments and provision of tissues.

Received for publication October 5, 2001; accepted October 10, 2001.

	Literature Cited

Top Summary Introduction Materials and Methods Results Discussion Literature Cited

Abedinia M, Pain T, Algar EM, Holmes RS (1990) Bovine corneal aldehyde dehydrogenase: the major soluble corneal protein with a possible dual protective role for the eye. Exp Eye Res 51:419-426[Medline]

Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9:836-844[Medline]

Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-1437[Abstract/Free Full Text]

Becquet F, Courtois Y, Goureau O (1997) Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol 42:71-82[Medline]

Behndig A, Karlsson K, Johansson BO, Brannstrom T, Marklund SL (2001) Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci 42:2293-2296[Abstract/Free Full Text]

Behndig A, Svensson B, Marklund SL, Karlsson K (1998) Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci 39:471-475[Abstract/Free Full Text]

Bhuyan DK, Master RW, Bhuyan KC (1996) Crosslinking of aminophospholipids in cellular membranes of lens by oxidative stress in vitro. Biochim Biophys Acta 1285:21-28[Medline]

Cross AH, Manning PT, Stern MK, Misko TP (1997) Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol 80:121-130[Medline]

Cursiefen C, Kuchle M, Naumann GO (1998) Changing indications for penetrating keratoplasty: histopathology of 1,250 corneal buttons. Cornea 17:468-470[Medline]

Dighiero P, Behar–Cohen F, Courtois Y, Goureau O (1997) Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol Vis Sci 38:2045-2052[Abstract/Free Full Text]

Downes JE, Swann PG, Holmes RS (1993) Ultraviolet light-induced pathology in the eye: associated changes in ocular aldehyde dehydrogenase and alcohol dehydrogenase activities. Cornea 12:241-248[Medline]

Downes JE, Swann PG, Holmes RS (1997) A genetic basis for corneal sensitivity to ultraviolet light among recombinant SWXJ inbred strains of mice. Curr Eye Res 16:539-546[Medline]

Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128[Medline]

Estrada C, Gomez C, Martin–Nieto J, De Frutos T, Jimenez A, Villalobo A (1997) Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase. Biochem J 326:369-376

Ganea E, Harding JJ (2000) Alpha-crystallin protects glucose 6-phosphate dehydrogenase against inactivation by malondialdehyde. Biochim Biophys Acta 1500:49-58[Medline]

Go YM, Patel RP, Maland MC, Park H, Beckman JS, Darley–Usmar VM, Jo H (1999) Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH(2)-terminal kinase. Am J Physiol 277:H1647-1653[Abstract/Free Full Text]

Gondhowiardjo TD, van Haeringen NJ (1993) Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas. Cornea 12:310-314[Medline]

Gondhowiardjo TD, van Haeringen NJ, Hoekzema R, Pels L, Kijlstra A (1991) Detection of aldehyde dehydrogenase activity in human corneal extracts. Curr Eye Res 10:1001-1007[Medline]

Gondhowiardjo TD, van Haeringen NJ, Volker–Dieben HJ, Beekhuis HW, Kok JH, van Rij G, Pels L, Kijlstra A (1993) Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea 12:146-154[Medline]

Gutteridge JM, Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15:129-135[Medline]

Jope RS, Zhang L, Song L (2000) Peroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells. Arch Biochem Biophys 376:365-370[Medline]

Kenney MC, Brown DJ, Rajeev B (2000) Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis. CLAO J 26:10-13[Medline]

Kenney MC, Chwa M, Alba A, Saghizadeh M, Huang ZS, Brown DJ (1998) Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res 17:238-246[Medline]

Kenney MC, Chwa M, Lin B, Huang GH, Ljubimov AV, Brown DJ (2001) Identification of cell types in human diseased corneas. Cornea 20:309-316[Medline]

Kim WJ, Rabinowitz YS, Meisler DM, Wilson SE (1999) Keratocyte apoptosis associated with keratoconus. Exp Eye Res 69:475-481[Medline]

Kiroycheva M, Ahmed F, Anthony GM, Szabo C, Southan GJ, Bank N (2000) Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice. J Am Soc Nephrol 11:1026-1032[Abstract/Free Full Text]

Kooy NW, Lewis SJ, Royall JA, Ye YZ, Kelly DR, Beckman JS (1997) Extensive tyrosine nitration in human myocardial inflammation: evidence for the presence of peroxynitrite. Crit Care Med 25:812-819[Medline]

Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS (1995) Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 151:1250-1254[Abstract]

Krachmer JH, Feder RS, Belin MW (1984) Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 28:293-322[Medline]

Liu E, Slomovic AR (1997) Indications for penetrating keratoplasty in Canada, 1986-1995. Cornea 16:414-419[Medline]

Lois N, Kowal VO, Cohen EJ, Rapuano CJ, Gault JA, Raber IM, Laibson PR (1997) Indications for penetrating keratoplasty and associated procedures, 1989-1995. Cornea 16:623-629[Medline]

McMenamin PG, Crewe JM (1997) Cellular localisation and dynamics of nitric oxide synthase expression in the rat anterior segment during endotoxin-induced uveitis. Exp Eye Res 65:157-164[Medline]

Murphy MP, Packer MA, Scarlett JL, Martin SW (1998) Peroxynitrite: a biologically significant oxidant. Gen Pharmacol 31:179-186[Medline]

Ohhira M, Ohtake T, Matsumoto A, Saito H, Ikuta K, Fujimoto Y, Ono M, Toyokuni S, Kohgo Y (1998) Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol Clin Exp Res 22:145S-149S[Medline]

Pappa A, Sophos NA, Vasiliou V (2001) Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals. Chem Biol Interact 130–132:181-191

Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P (1997) In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology 26:135-142[Medline]

Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819-824[Medline]

Rabinowitz YS (1998) Keratoconus. Surv Ophthalmol 42:297-319[Medline]

Rao NA, Romero JL, Fernandez MA, Sevanian A, Marak GE, Jr (1987) Role of free radicals in uveitis. Surv Ophthalmol 32:209-213[Medline]

Saleh D, Barnes PJ, Giaid A (1997) Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155:1763-1769[Abstract]

Shiao T, Tran P, Siegel D, Lee J, Vasiliou V (1999) Four amino acid changes are associated with the ALDH3A1 locus polymorphism in mice which may be responsible for corneal sensitivity to ultraviolet light. Pharmacogenetics 9:145-153[Medline]

Szabo C, Ohshima H (1997) DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1:373-385[Medline]

Wenk J, Brenneisen P, Meewes C, Wlaschek M, Peters T, Blaudschun R, Ma W, Kuhr L, Schneider L, Scharffetter–Kochanek K (2001) UV-induced oxidative stress and photoaging. Curr Probl Dermatol 29:83-94[Medline]

Yanagiya N, Akiba J, Kado M, Yoshida A, Kono T, Iwamoto J (1997) Transient corneal edema induced by nitric oxide synthase inhibition. Nitric Oxide 1:397-403[Medline]

Yoshino H, Hattori N, Urabe T, Uchida K, Tanaka M, Mizuno Y (1997) Postischemic accumulation of lipid peroxidation products in the rat brain: immunohistochemical detection of 4-hydroxy-2-nonenal modified proteins. Brain Res 767:81-86[Medline]

Zhou L, Yue BY, Twining SS, Sugar J, Feder RS (1996) Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res 15:1124-1131[Medline]

Zhou XJ, Laszik Z, Wang XQ, Silva FG, Vaziri ND (2000) Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 80:1905-1914[Medline]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Chwa, S. R. Atilano, D. Hertzog, H. Zheng, J. Langberg, D. W. Kim, and M. C. Kenney Hypersensitive Response to Oxidative Stress in Keratoconus Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4361 - 4369. [Abstract] [Full Text] [PDF]

				U. V. Jurkunas, M. S. Bitar, I. Rawe, D. L. Harris, K. Colby, and N. C. Joyce Increased Clusterin Expression in Fuchs' Endothelial Dystrophy Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2946 - 2955. [Abstract] [Full Text] [PDF]

				U. V. Jurkunas, I. Rawe, M. S. Bitar, C. Zhu, D. L. Harris, K. Colby, and N. C. Joyce Decreased Expression of Peroxiredoxins in Fuchs' Endothelial Dystrophy Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2956 - 2963. [Abstract] [Full Text] [PDF]

				M. Aslan, I. Yucel, A. Ciftcioglu, B. Savas, Y. Akar, G. Yucel, and S. Sanlioglu Corneal Protein Nitration in Experimental Uveitis Experimental Biology and Medicine, November 1, 2007; 232(10): 1308 - 1313. [Abstract] [Full Text] [PDF]

				K. M. Newkirk, H. L. Chandler, A. E. Parent, D. C. Young, C. M. H. Colitz, D. A. Wilkie, and D. F. Kusewitt Ultraviolet Radiation-Induced Corneal Degeneration in 129 Mice Toxicol Pathol, October 1, 2007; 35(6): 817 - 824. [Abstract] [Full Text] [PDF]

				N. Lassen, J. B. Bateman, T. Estey, J. R. Kuszak, D. W. Nees, J. Piatigorsky, G. Duester, B. J. Day, J. Huang, L. M. Hines, et al. Multiple and Additive Functions of ALDH3A1 and ALDH1A1: CATARACT PHENOTYPE AND OCULAR OXIDATIVE DAMAGE IN Aldh3a1(-/-)/Aldh1a1(-/-) KNOCK-OUT MICE J. Biol. Chem., August 31, 2007; 282(35): 25668 - 25676. [Abstract] [Full Text] [PDF]

				Q. Cheng, T. Nguyen, H. Song, and J. Bonanno Hypoxia Protects Human Corneal Endothelium from Tertiary Butyl Hydroperoxide and Paraquat-Induced Cell Death In Vitro Experimental Biology and Medicine, March 1, 2007; 232(3): 445 - 453. [Abstract] [Full Text] [PDF]

				N. Udar, S. R. Atilano, D. J. Brown, B. Holguin, K. Small, A. B. Nesburn, and M. C. Kenney SOD1: A Candidate Gene for Keratoconus. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3345 - 3351. [Abstract] [Full Text] [PDF]

				F. Chiambaretta, H. Nakamura, F. De Graeve, H. Sakai, G. Marceau, Y. Maruyama, D. Rigal, B. Dastugue, J. Sugar, B. Y. J. T. Yue, et al. Kruppel-like Factor 6 (KLF6) Affects the Promoter Activity of the {alpha}1-Proteinase Inhibitor Gene Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 582 - 590. [Abstract] [Full Text] [PDF]

				A A Assiri, B I Yousuf, A J Quantock, and P J Murphy Incidence and severity of keratoconus in Asir province, Saudi Arabia Br. J. Ophthalmol., November 1, 2005; 89(11): 1403 - 1406. [Abstract] [Full Text] [PDF]

				S. R. Atilano, P. Coskun, M. Chwa, N. Jordan, V. Reddy, K. Le, D. C. Wallace, and M. C. Kenney Accumulation of Mitochondrial DNA Damage in Keratoconus Corneas Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1256 - 1263. [Abstract] [Full Text] [PDF]

				M. C. Kenney, M. Chwa, S. R. Atilano, A. Tran, M. Carballo, M. Saghizadeh, V. Vasiliou, W. Adachi, and D. J. Brown Increased Levels of Catalase and Cathepsin V/L2 but Decreased TIMP-1 in Keratoconus Corneas: Evidence that Oxidative Stress Plays a Role in This Disorder Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 823 - 832. [Abstract] [Full Text] [PDF]

				P. Sagoo, G. Chan, D. F. P. Larkin, and A. J. T. George Inflammatory Cytokines Induce Apoptosis of Corneal Endothelium through Nitric Oxide Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3964 - 3973. [Abstract] [Full Text] [PDF]

				B. Norman, J. Davis, and J. Piatigorsky Postnatal Gene Expression in the Normal Mouse Cornea by SAGE Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 429 - 440. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buddi, R. Articles by Brown, D. J.